We chose to screen for resistance associated with streptomycin (strA/B) and sulfonamide (sul1/2), because these genes can be present in the SXT constin, and with erythromycin (ermA/B, mefA) which is used in Haiti for cholera treatment. This evidence concerns the gene TMEM94 and vibrio infectious disease.